
Metoprolol Succinate (25mg) + Efonidipine (40mg)
Active composition
+1 more active ingredient
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Efonidipine inhibits calcium channels, leading to vasodilation and reduced cardiac workload.
Medical applications
Efnocar-MX 40/25 Tablet MR is a combination medication used in the management of high blood pressure and certain heart conditions. It contains Efonidipine 40mg, a calcium channel blocker that helps relax blood vessels, and Metoprolol Succinate 25mg, a beta-blocker that slows the heart rate and reduces the workload on the heart. The modified-release formulation ensures gradual release of the medication for sustained blood pressure control throughout the day. This combination helps improve cardiovascular function and reduces the risk of complications associated with hypertension when used under medical supervision.
How to use Efnocar-MX Tablet MR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Efnocar-MX 40/25 Tablet MR may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is not known whether it is safe to consume alcohol with Efnocar-MX 40/25 Tablet MR. Please consult your doctor.
High Risk
Efnocar-MX 40/25 Tablet MR is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
It is not known whether Efnocar-MX 40/25 Tablet MR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
There is limited information available on the use of Efnocar-MX 40/25 Tablet MR in patients with liver disease. Please consult your doctor.
Regular Checkup
Information regarding the use of Efnocar-MX 40/25 Tablet MR during breastfeeding is not available. Please consult your doctor.
Consult Doctor
There is limited information available on the use of Efnocar-MX 40/25 Tablet MR in patients with kidney disease. Please consult your doctor.
Regular Checkup
0 reviews for Efnocar-MX 40/25 Tablet MR

Efonidipine (40mg) + Metoprolol Succinate (25mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Efonidipine inhibits calcium channels, leading to vasodilation and reduced cardiac workload.
Medical applications
Efnocar-MX 40/25 Tablet MR is a combination medication used in the management of high blood pressure and certain heart conditions. It contains Efonidipine 40mg, a calcium channel blocker that helps relax blood vessels, and Metoprolol Succinate 25mg, a beta-blocker that slows the heart rate and reduces the workload on the heart. The modified-release formulation ensures gradual release of the medication for sustained blood pressure control throughout the day. This combination helps improve cardiovascular function and reduces the risk of complications associated with hypertension when used under medical supervision.
How to use Efnocar-MX Tablet MR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Efnocar-MX 40/25 Tablet MR may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is not known whether it is safe to consume alcohol with Efnocar-MX 40/25 Tablet MR. Please consult your doctor.
High Risk
Efnocar-MX 40/25 Tablet MR is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
It is not known whether Efnocar-MX 40/25 Tablet MR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
There is limited information available on the use of Efnocar-MX 40/25 Tablet MR in patients with liver disease. Please consult your doctor.
Regular Checkup
Information regarding the use of Efnocar-MX 40/25 Tablet MR during breastfeeding is not available. Please consult your doctor.
Consult Doctor
There is limited information available on the use of Efnocar-MX 40/25 Tablet MR in patients with kidney disease. Please consult your doctor.
Regular Checkup
0 reviews for Efnocar-MX 40/25 Tablet MR















